We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Adeia
ADEA
$3.11B
| $1.95M | 0.01% |
183,402
-131,680
| -42% | -$1.35M |
|
|
CBR
602
DELISTED
CIBER Inc.
CBR
| $1.94M | 0.01% |
471,415
+73,767
| +19% | +$275K |
|
|
LORL
603
DELISTED
Loral Space and Communications, Inc.
LORL
| $1.93M | 0.01% |
28,132
| – | – |
|
604
Take-Two Interactive
TTWO
$46.1B
| $1.9M | 0.01% |
74,766
-73,795
| -50% | -$2.01M |
|
605
Emcor
EME
$36B
| $1.9M | 0.01% |
40,777
| – | – |
|
606
iShares MSCI United Kingdom ETF
EWU
$4.16B
| $1.89M | 0.01% |
52,588
-3,078
| -6% | -$113K |
|
|
AVG
607
DELISTED
AVG Technologies N.V.
AVG
| $1.87M | 0.01% |
86,452
-10,800
| -11% | -$227K |
|
|
MLNX
608
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.86M | 0.01% |
+41,000
| New | +$1.88M |
|
|
OMG
609
DELISTED
OM GROUP INC.
OMG
| $1.85M | 0.01% |
61,655
+34,964
| +131% | +$1.02M |
|
610
Diodes
DIOD
$4.84B
| $1.84M | 0.01% |
64,547
+49,594
| +332% | +$1.39M |
|
|
EVRI
611
DELISTED
Everi Holdings
EVRI
| $1.84M | 0.01% |
241,143
-71,018
| -23% | -$506K |
|
612
Ingles Markets
IMKTA
$1.67B
| $1.83M | 0.01% |
36,965
-67,671
| -65% | -$3.04M |
|
|
INXN
613
DELISTED
Interxion Holding N.V.
INXN
| $1.82M | 0.01% |
64,485
| – | – |
|
614
Constellation Brands
STZ
$23.2B
| $1.81M | 0.01% |
15,600
-128,882
| -89% | -$14.5M |
|
615
Coca-Cola Europacific Partners
CCEP
$47.9B
| $1.81M | 0.01% |
+40,860
| New | +$1.78M |
|
|
SUSQ
616
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $1.8M | 0.01% |
131,035
-101,376
| -44% | -$1.35M |
|
|
RENX
617
DELISTED
RELX N.V.
RENX
| $1.75M | 0.01% |
108,320
+35,719
| +49% | +$572K |
|
|
DRII
618
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $1.74M | 0.01% |
52,180
+5,349
| +11% | +$168K |
|
619
V2X
VVX
$2.65B
| $1.73M | 0.01% |
67,976
-27,049
| -28% | -$782K |
|
620
Ribbon Communications
RBBN
$383M
| $1.73M | 0.01% |
219,029
+204,919
| +1,452% | +$3.38M |
|
|
MWW
621
DELISTED
Monster Worldwide Inc
MWW
| $1.72M | 0.01% |
270,875
-68,706
| -20% | -$377K |
|
622
National Presto Industries
NPK
$989M
| $1.7M | 0.01% |
26,737
-635
| -2% | -$39.1K |
|
|
NEWP
623
DELISTED
NEWPORT CORP
NEWP
| $1.68M | 0.01% |
88,305
-5,745
| -6% | -$111K |
|
624
EOG Resources
EOG
$70.7B
| $1.68M | 0.01% |
18,265
-8,800
| -33% | -$795K |
|
625
Core Laboratories
CLB
$521M
| $1.67M | 0.01% |
+16,000
| New | +$1.7M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.